- Home
- VSTM vs PETS Comparison
VSTM vs PETS Comparison
Compare VSTM & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- PETS
- Stock Information
- Founded
- VSTM 2010
- PETS 1996
- Country
- VSTM United States
- PETS United States
- Employees
- VSTM N/A
- PETS N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- VSTM Health Care
- PETS Consumer Staples
- Exchange
- VSTM Nasdaq
- PETS Nasdaq
- Market Cap
- VSTM 132.0M
- PETS 82.0M
- IPO Year
- VSTM 2012
- PETS N/A
- Fundamental
- Price
- VSTM $3.88
- PETS $4.02
- Analyst Decision
- VSTM Strong Buy
- PETS Sell
- Analyst Count
- VSTM 8
- PETS 2
- Target Price
- VSTM $14.57
- PETS $3.50
- AVG Volume (30 Days)
- VSTM 1.1M
- PETS 182.6K
- Earning Date
- VSTM 11-06-2024
- PETS 11-06-2024
- Dividend Yield
- VSTM N/A
- PETS 29.41%
- EPS Growth
- VSTM N/A
- PETS N/A
- EPS
- VSTM N/A
- PETS N/A
- Revenue
- VSTM $10,000,000.00
- PETS $270,772,000.00
- Revenue This Year
- VSTM N/A
- PETS N/A
- Revenue Next Year
- VSTM $125.69
- PETS $3.27
- P/E Ratio
- VSTM N/A
- PETS N/A
- Revenue Growth
- VSTM N/A
- PETS 2.26
- 52 Week Low
- VSTM $2.10
- PETS $2.90
- 52 Week High
- VSTM $14.22
- PETS $8.27
- Technical
- Relative Strength Index (RSI)
- VSTM 63.77
- PETS 56.76
- Support Level
- VSTM $3.11
- PETS $3.78
- Resistance Level
- VSTM $3.76
- PETS $4.17
- Average True Range (ATR)
- VSTM 0.33
- PETS 0.18
- MACD
- VSTM 0.04
- PETS -0.01
- Stochastic Oscillator
- VSTM 94.26
- PETS 62.22
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.